Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells Grant US-11932696-B2 United States of America 19 Mar 2024
Formulations of oxabicycloheptanes and oxabicycloheptenes Grant US-11931354-B2 United States of America 19 Mar 2024
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE Application EP-4324477-A2 European Patent Office 21 Feb 2024
Dosing regimen for GP100-specific TCR—anti-CD3 SCFV fusion protein Grant US-11827688-B2 United States of America 28 Nov 2023